Hims & Hers Health Investors With Losses Can Lead Lawsuit
Purchasers of Hims & Hers Health, Inc. (NYSE: HIMS) securities during a specific period have the opportunity to be appointed lead plaintiff in a class action lawsuit. The deadline for appointment is November 2.
Hims & Hers Health, Inc. (NYSE: HIMS) faces a potential class action lawsuit initiated by investors who claim substantial losses. Purchasers or acquirers of the company's securities between August 4, 2025, and July 29, 2026, are eligible to seek appointment as lead plaintiff.
The legal action centers on allegations of violations of federal securities laws. The court aims to determine if the company made misleading or incomplete statements regarding its business during the specified "class period."
Eligible investors have until November 2, 2026, to file a motion with the court to be appointed as the lead plaintiff. This role allows them to guide the lawsuit on behalf of all class members.
Robbins Geller Rudman & Dowd LLP, a law firm specializing in securities litigation, announced the opportunity for investors to participate. The firm is guiding potential lead plaintiffs through the application process.